Showing results (31-40 of 79) with videos related to
Sort By:
Pageof 8
Oncotarget|March 18, 2020
The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancerEmma R Dorris, Amanda O'Neill, Ann Treacy, et al.BMC Cancer|April 3, 2019
NUP98 - a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancerPaul B Mullan, Victoria Bingham, Paula Haddock, et al.BMC Cancer|August 19, 2022
Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patientsShereen El Mashed, Tracey R O'Donovan, Elaine Kay, et al.Apoptosis : an International Journal on Programmed Cell Death|August 5, 2010
In vitro and in vivo characterisation of a novel c-FLIP-targeted antisense phosphorothioate oligonucleotideAndrew E Logan, Timothy R Wilson, Catherine Fenning, et al.Journal of Cutaneous Pathology|June 13, 2009
Investigation of the effect of UV irradiation on DNA damage: comparison between skin cancer patients and normal volunteersMohamed J E M F Mabruk, Lim K Toh, Miriam Murphy, et al.Molecular Imaging|May 15, 2004
Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viabilityAli Syed Arbab, Gene Thomus Yocum, Lindsey Bashaw Wilson, et al.BJU International|December 2, 2008
Urinary insulin-like growth factor 2 identifies the presence of urothelial carcinoma of the bladderJenny A Watson, Keith Burling, Patricia Fitzpatrick, et al.International Journal of Cancer|December 10, 2002
Infiltrating immune cells, but not tumour cells, express FasL in non-small cell lung cancer: No association with prognosis identified in 3-year follow-upDeirdre Toomey, Gordon Smyth, Claire Condron, et al.Journal of Clinical Pathology|September 12, 2006
External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot schemeJohn M S Bartlett, Merdol Ibrahim, Bharat Jasani, et al.Human Pathology|May 6, 2014
Spindle assembly checkpoint protein expression correlates with cellular proliferation and shorter time to recurrence in ovarian cancerBarbara McGrogan, Sine Phelan, Patricia Fitzpatrick, et al.Pageof 8